Millennium Management’s Inovio Pharmaceuticals INO Stock Holding History

Millennium Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,500	Closed	-$1.07M	–	7082
2021 Q3	$1.07M	Buy	12,500 +4,167	+50%	+$418K	﹤0.01%	4597
2021 Q2	$927K	Sell	8,333 -20,609	-71%	-$1.98M	﹤0.01%	4733
2021 Q1	$3.22M	Sell	28,942 -225	-0.8%	-$29.6K	﹤0.01%	3061
2020 Q4	$3.1M	Buy	+29,167	New	+$3.88M	﹤0.01%	2874
2020 Q3	–	Sell	-4,167	Closed	-$1.35M	–	4623
2020 Q2	$1.35M	Buy	+4,167	New	+$669K	﹤0.01%	2808

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's INO Position: Q1 2026 in Review

Millennium Management increased its Inovio Pharmaceuticals (INO) stake by 0.53% in Q1 2026, buying an estimated $12.3K and bringing the position to 1,410,845 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3674.

Millennium Management first reported a position in INO in Q1 2014 and has held it in 37 quarters since. The position peaked at $12.6M in Q1 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

Millennium Management held 1,410,845 shares of Inovio Pharmaceuticals worth $2.45M as of Q1 2026.
Millennium Management bought 7,466 Inovio Pharmaceuticals shares in Q1 2026, an estimated $12.3K.
Inovio Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3674 holding.
Millennium Management first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 37 quarters since.
Millennium Management's Inovio Pharmaceuticals position peaked at $12.6M in Q1 2020.
100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.